keyword
https://read.qxmd.com/read/36470224/patterns-of-surgical-recurrence-in-patients-with-hidradenitis-suppurativa
#81
JOURNAL ARTICLE
Carlos Cuenca-Barrales, Trinidad Montero-Vílchez, Manuel Sanchez-Diaz, Juan-Ángel Rodríguez-Pozo, Pablo Díaz-Calvillo, Antonio Martinez-Lopez, Salvador Arias-Santiago, Alejandro Molina-Leyva
BACKGROUND: Surgery is an essential part of hidradenitis suppurativa (HS) treatment. Understanding and reducing surgical recurrence are crucial to obtaining the best results in patients' treatment. OBJECTIVE: The aim of the study was to characterize surgical recurrences in a cohort of patients with HS treated with wide excision and second-intention healing. METHODS: A prospective nested case-control study was conducted. A cohort of patients with HS treated with wide excision and second-intention healing was monitored for 68 weeks...
December 5, 2022: Dermatology: International Journal for Clinical and Investigative Dermatology
https://read.qxmd.com/read/36388895/sex-disaggregated-population-analysis-in-patients-with-hidradenitis-suppurativa
#82
JOURNAL ARTICLE
Robert Sabat, Athanasia Tsaousi, Kamran Ghoreschi, Kerstin Wolk, Sylke Schneider-Burrus
Background: Hidradenitis suppurativa (HS) is a common chronic inflammatory skin disease, which affects both sexes. Objectives: Identification of sex-specific risk factors, comorbidity, clinical manifestations, and treatments in HS patients. Methods: A non-interventional, cross-sectional, mono-centric study with 500 HS patients. All patients were examined by dermatologists. Prospectively collected demographic, anamnestic, clinical data, and blood parameters were evaluated...
2022: Frontiers in Medicine
https://read.qxmd.com/read/36291580/transcriptome-meta-analysis-confirms-the-hidradenitis-suppurativa-pathogenic-triad-upregulated-inflammation-altered-epithelial-organization-and-dysregulated-metabolic-signaling
#83
JOURNAL ARTICLE
Ana Sofia Lima Estevao de Oliveira, Giovanna Bloise, Chiara Moltrasio, Antonio Coelho, Almerinda Agrelli, Ronald Moura, Paola Maura Tricarico, Stéphane Jamain, Angelo Valerio Marzano, Sergio Crovella, Lucas André Cavalcanti Brandão
Hidradenitis suppurativa (HS) is an inflammatory skin condition clinically characterized by recurrent painful deep-seated nodules, abscesses, and sinus tracks in areas bearing apocrine glands, such as axillae, breasts, groins, and buttocks. Despite many recent advances, the pathophysiological landscape of HS still demands further clarification. To elucidate HS pathogenesis, we performed a meta-analysis, set analysis, and a variant calling on selected RNA-Sequencing (RNA-Seq) studies on HS skin. Our findings corroborate the HS triad composed of upregulated inflammation, altered epithelial differentiation, and dysregulated metabolism signaling...
September 25, 2022: Biomolecules
https://read.qxmd.com/read/36232581/microbiome-in-hidradenitis-suppurativa-what-we-know-and-where-we-are-heading
#84
REVIEW
Zuzanna Świerczewska, Miłosz Lewandowski, Agnieszka Surowiecka, Wioletta Barańska-Rybak
Recently, interest in the microbiome of cutaneous diseases has increased tremendously. Of particular interest is the gut-brain-skin axis proposed by Stokes and Pillsbury in 1930. The microbiome has been suggested in the pathogenesis of hidradenitis suppurativa, however the link between the commensals and the host is yet to be established. Across all studies, the increased abundance of Porphyromonas , Peptoniphilus, and Prevotella spp., and a loss of skin commensal species, such as Cutibacterium in HS lesions, is a consistent finding...
September 24, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36143456/characteristics-of-the-skin-microbiome-in-selected-dermatological-conditions-a-narrative-review
#85
REVIEW
Esther Olunoiki, Jacqueline Rehner, Markus Bischoff, Elena Koshel, Thomas Vogt, Jörg Reichrath, Sören L Becker
The skin is the largest and outermost organ of the human body. The microbial diversity of the skin can be influenced by several variable factors such as physiological state, lifestyle, and geographical locations. Recent years have seen increased interest in research aiming at an improved understanding of the relationship between the human microbiota and several diseases. Albeit understudied, interesting correlations between the skin microbiota and several dermatological conditions have been observed. Studies have shown that a decrease or increase in the abundance of certain microbial communities can be implicated in several dermatological pathologies...
September 12, 2022: Life
https://read.qxmd.com/read/36122570/can-ultrasound-examinations-generate-pain-in-hidradenitis-suppurativa-patients-results-from-a-multicentric-cross-sectional-study
#86
JOURNAL ARTICLE
Ximena Wortsman, Francisco Reyes-Baraona, Cristian Ramirez-Cornejo, Camila Ferreira-Wortsman, Raffaele Dante Caposiena Caro, Alejandro Molina-Leyva, Salvador Arias-Santiago, Priscila Giavedoni, Antonio Martorell, Jorge Romani, Claudia Gonzalez, Fernando Alfageme
BACKGROUND: Pain is not a trivial issue for hidradenitis suppurativa (HS) patients and has been considered a domain in the Core Outcome Set. To date, there is no evidence about pain caused by the ultrasound examinations. OBJECTIVE: The aim of the study was to assess the presence of pain generated by the ultrasound examinations of HS patients. METHODS: A multicentric cross-sectional study for detecting pain during the ultrasound examinations of HS patients using a validated verbal questionnaire immediately after the imaging studies...
September 19, 2022: Dermatology: International Journal for Clinical and Investigative Dermatology
https://read.qxmd.com/read/36108592/demographic-gaps-and-requirements-for-participation-a-systematic-review-of-clinical-trial-designs-in-hidradenitis-suppurativa
#87
JOURNAL ARTICLE
JaBreia Fanita James, Victoria M Madray, Nicole Salame, Samar Babikir Hasan, Mia Sohn White, Jason Richard Barron, Joslyn Kirby, John Robert Ingram, Lauren Anne Vigil Orenstein
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory disease that disproportionally affects women, as well as Black and biracial individuals. While adalimumab remains the only therapy approved by the Food and Drug Administration for HS, many HS clinical trials for novel and re-tasked therapies are ongoing or upcoming. To optimize treatment equity, reflect the patient population, and facilitate trial participation, it is important to elucidate aspects of clinical trial protocols that may systematically exclude specific patient groups or impose hardships...
September 15, 2022: Dermatology: International Journal for Clinical and Investigative Dermatology
https://read.qxmd.com/read/36098675/s2k-guideline-laser-therapy-of-the-skin
#88
JOURNAL ARTICLE
Uwe Paasch, Miriam Zidane, Jens Malte Baron, Thorsten Bund, Hans-Joachim Cappius, Michael Drosner, Konstantin Feise, Tanja Fischer, Gerd Gauglitz, Peter Arne Gerber, Sonja Grunewald, Katharina Herberger, Anja Jung, Syrus Karsai, Gerd Kautz, Carsten Philipp, Daniela Schädel, Anna-Theresa Seitz, Alexander Nast
This guideline aims to improve the efficiency and safety of lasers and optical radiation sources with similar effects (especially IPL). Laser therapy of skin lesions with an increased amount of melanocytes should be performed with caution. Laser treatment of pigmented melanocytic nevi is not recommended. The guideline contains recommendations regarding the treatment of lentigines and café-au-lait spots, non-pigmented dermal nevi, Becker nevus, nevus of Ota/Hori/Ito and melasma. Further recommendations focus on the treatment of skin lesions without an increased amount of melanocytes (ephelides, postinflammatory hyperpigmentation including berloque dermatitis, seborrheic keratoses, traumatic/decorative tattoos and metallic deposits), hypopigmentation (vitiligo), benign non-pigmented neoplasms (fibrous papule of the nose, nevus sebaceus, epidermal nevus, neurofibroma, sebaceous gland hyperplasia, syringoma, xanthelasma palpebrarum), inflammatory dermatoses (acne papulopustulosa/conglobata, acne inversa, granuloma faciale, lichen sclerosus, lupus erythematosus, psoriasis vulgaris, rosacea, rhinophyma), wrinkles/dermatochalasis/striae, hypertrichosis, scars (atrophic, hypertrophic; keloids, burn/scald scars), laser-assisted skin healing, onychomycosis, precancerous lesions and malignant tumors (actinic keratoses/field cancerization, cheilitis actinica, basal cell carcinoma), vascular skin lesions (angiokeratoma, angioma, hemangioma, malformation, spider veins, granuloma telangiectaticum (pyogenic granuloma), rubeosis (erythrosis interfollicularis colli, ulerythema ophryogenes), nevus flammeus, telangiectasias and Osler's disease (hereditary hemorrhagic telangiectasia) and viral skin lesions (condylomata acuminata, mollusca contagiosa, verrucae planae juveniles/vulgares/ verrucae palmares et plantares)...
September 2022: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/36077114/immunomodulatory-drugs-in-the-treatment-of-hidradenitis-suppurativa-possibilities-and-limitations
#89
REVIEW
Zuzanna Świerczewska, Miłosz Lewandowski, Agnieszka Surowiecka, Wioletta Barańska-Rybak
Hidradenitis suppurativa, also known as acne inversa, is a chronic, progressive, debilitating, recurrent inflammatory skin disease characterized by the occurrence of very severe, persistent, painful nodules, abscesses, and fistulas, most commonly found in the skin folds of the axilla, groin, gluteal, and perianal areas. Treatment is rather difficult and typically requires the use of multiple modalities. Regardless of the presence of several therapeutic options, treatment often turns out to be ineffective or poorly selected concerning the clinical picture of the disease...
August 26, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36047363/surgical-view-of-morphological-and-pathogenetic-identity-of-pilonidal-cysts-and-acne-inversa
#90
JOURNAL ARTICLE
Ihor Balan, Yaroslav Feleshtynskyi, Olena Dyadyk, Julia Beketova
<b>Introduction:</b> As a rule, the treatment of pilonidal cysts is based on a surgical approach. Surgical treatment depends on the form of the disease and surgeon's preferences regarding the method. The treatment process does not consider preoperative treatment that would affect the structural components of the skin involved in the pathological process. The results of surgical treatment remain unsatisfactory, leading to a significant number of recurrences and long-term healing of the postoperative wound...
February 11, 2022: Polski Przeglad Chirurgiczny
https://read.qxmd.com/read/36012322/phytotherapeuthics-affecting-the-il-1-il-17-g-csf-axis-a-complementary-treatment-option-for-hidradenitis-suppurativa
#91
REVIEW
Katrin Witte, Robert Sabat, Ellen Witte-Händel, Kamran Ghoreschi, Kerstin Wolk
Hidradenitis suppurativa (HS; also designated as acne inversa) is a chronic inflammatory disease characterized by painful skin lesions that occur in the axillary, inguinal, gluteal and perianal areas of the body. These lesions contain recurring deep-seated, inflamed nodules and pus-discharging abscesses and fistulas. Affecting about 1% of the population, this common disease has gained appropriate clinical attention in the last years. Associated with numerous comorbidities including metabolic syndrome, HS is considered a systemic disease that severely impairs the quality of life and shortens life expectancy...
August 13, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36009585/hidradenitis-suppurativa-a-perspective-on-genetic-factors-involved-in-the-disease
#92
JOURNAL ARTICLE
Chiara Moltrasio, Paola Maura Tricarico, Maurizio Romagnuolo, Angelo Valerio Marzano, Sergio Crovella
Hidradenitis Suppurativa (HS) is a chronic inflammatory skin disease of the pilosebaceous unit, clinically consisting of painful nodules, abscesses, and sinus tracts mostly in, but not limited to, intertriginous skin areas. HS can be defined as a complex skin disease with multifactorial etiologies, including-among others-genetic, immunologic, epigenetic, and environmental factors. Based on genetic heterogeneity and complexity, three different forms can be recognized and considered separately as sporadic, familial, and syndromic...
August 21, 2022: Biomedicines
https://read.qxmd.com/read/35998557/validity-and-reliability-of-two-digital-wound-measurement-tools-after-surgery-in-patients-with-hidradenitis-suppurativa
#93
JOURNAL ARTICLE
Pim Aarts, Johanna C van Huijstee, Aviël Ragamin, Joanne L Reeves, Catherine van Montfrans, Hessel H van der Zee, Errol P Prens
BACKGROUND: After excision surgery in patients with hidradenitis suppurativa (HS), wounds are usually left open for secondary intention healing. To evaluate wound healing, reliable wound measurement is important. However, digital wound measurement tools for measuring the surface area are validated for small wounds located on flat or mildly convex body surfaces in studies, often powered inadequately. Up until now, a validated digital measurement tool to accurately measure wounds on all body surfaces, including the intertriginous areas, was not available...
August 23, 2022: Dermatology: International Journal for Clinical and Investigative Dermatology
https://read.qxmd.com/read/35967376/innate-immunity-and-microbial-dysbiosis-in-hidradenitis-suppurativa-vicious-cycle-of-chronic-inflammation
#94
REVIEW
Divya Chopra, Rachel A Arens, Watcharee Amornpairoj, Michelle A Lowes, Marjana Tomic-Canic, Natasa Strbo, Hadar Lev-Tov, Irena Pastar
Hidradenitis Suppurativa (HS) is a chronic multifactorial inflammatory skin disease with incompletely understood mechanisms of disease pathology. HS is characterized by aberrant activation of the innate immune system, resulting in activation of pathways that aim to protect against pathogenic microorganisms, and also contribute to failure to resolve inflammation. Imbalance in innate immunity is evident in deregulation of host antimicrobial peptides (AMPs) and the complement system associated with the microbiome dysbiosis...
2022: Frontiers in Immunology
https://read.qxmd.com/read/35934210/real-world-safety-and-clinical-response-of-janus-kinase-inhibitor-upadacitinib-in-the-treatment-of-hidradenitis-suppurativa-a-retrospective-cohort-study
#95
JOURNAL ARTICLE
Emily Kozera, Akshay Flora, John W Frew
No abstract text is available yet for this article.
August 4, 2022: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/35892482/histopathology-of-hidradenitis-suppurativa-a-systematic-review
#96
REVIEW
Shane David Basil Smith, Ginette A Okoye, Olayemi Sokumbi
Hidradenitis suppurativa (HS) is a chronic inflammatory scarring disease felt to be related to occlusion of the hair follicle unit in intertriginous areas. We perform a systematic review on HS histopathology to evaluate current knowledge and discuss future directions. PubMed and Scopus databases were searched for relevant articles published from January 1985 to January 2021 that discussed the pathology of HS. Additional articles were identified by hand-searching, which entailed manually scanning selected journals...
July 14, 2022: Dermatopathology (Basel, Switzerland)
https://read.qxmd.com/read/35887799/similar-levels-of-efficacy-of-two-different-maintenance-doses-of-adalimumab-on-clinical-severity-and-quality-of-life-of-patients-with-hidradenitis-suppurativa
#97
JOURNAL ARTICLE
Luca Fania, Giulia Giovanardi, Tonia Samela, Dante Caposiena, Andrea Chiricozzi, Flaminia Antonelli, Pierluigi Saraceni, Fulvia Elia, Simone Garcovich, Davide Ciccone, Maria Vittoria Cannizzaro, Emanuele Miraglia, Chiara Iacovino, Sandra Giustini, Nevena Skroza, Alessandra Mambrin, Concetta Potenza, Luca Bianchi, Ketty Peris, Damiano Abeni
Adalimumab is the only biologic agent approved for the treatment of moderate-to-severe hidradenitis suppurativa (HS) patients (i.e., with Hurley II or III), which is recommended in two different maintenance doses (i.e., 40 mg weekly or 80 mg every two weeks). We conducted a prospective multicentric study to measure outcomes related to the severity of disease and quality of life (QoL) of patients affected by moderate-to-severe HS, treated with adalimumab at a maintenance dosing of 40 mg or 80 mg. Assessments were performed at baseline (T0) and after 32 weeks of treatment (T32)...
July 12, 2022: Journal of Clinical Medicine
https://read.qxmd.com/read/35881108/stress-signaling-and-stat1-activation-characterize-the-keratinocytic-gene-expression-pattern-in-hidradenitis-suppurativa
#98
JOURNAL ARTICLE
V G Frings, L Jopp, M Srivastava, D Presser, M Goebeler, M Schmidt
BACKGROUND: The pathogenetic factors generating the innate immune signal necessary for T cell activation, initiation and chronification of Hidradenitis suppurativa (HS, also known as Acne inversa) are still poorly understood. Emerging evidence suggests that a defective keratinocyte function critically contributes to HS disease development and progression. OBJECTIVES: To elucidate the role of keratinocytes in HS lesion formation, we compared the transcriptomes of lesional and perilesional epidermis isolated from HS patients by RNA sequencing (RNA Seq)...
July 26, 2022: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/35843211/effects-of-ncstn-mutation-on-hair-follicle-components-in-mice
#99
JOURNAL ARTICLE
Tian-Wei Shi, Wei Cao, Qing-Zan Zhao, Hong-Xing Yu, Si-Sen Zhang, Yi-Bin Hao
BACKGROUND AND OBJECTIVES: Hidradenitis suppurativa (HS)/acne inversa is an intractable skin disease that is characterized by destructive lesions - primarily on the flexural areas. Although its etiology is unknown, genetics is considered to be a factor of its pathology - mutations in γ-secretase genes have been identified in certain familial HS patients, and follicular occlusion is widely accepted as the primary cause of HS. But, no relationship between these mutations and the components of hair follicles has been reported...
July 15, 2022: Dermatology: International Journal for Clinical and Investigative Dermatology
https://read.qxmd.com/read/35836613/the-value-of-negative-pressure-wound-therapy-and-flap-surgery-in-hidradenitis-suppurativa-a-single-center-analysis-of-different-treatment-options
#100
JOURNAL ARTICLE
M C Stumpfe, R E Horch, A Arkudas, A Cai, W Müller-Seubert, T Hauck, I Ludolph
Background: Hidradenitis suppurativa is manifested by painful abscesses and scarring of sweat glands. Axillary, inguinal and genital regions are mostly affected. Multiple options exist in the treatment of hidradenitis suppurativa. The aim of this retrospective, mono-center cohort study was to analyze the outcome of different treatment methods after radical excision of hidradenitis suppurativa. Methods: We retrospectively evaluated the treatment strategy and recurrence rate of hidradenitis suppurativa...
2022: Frontiers in Surgery
keyword
keyword
73236
5
6
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.